Xiocare Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.00 M
- Revenue Growth 23.95%
- Profit Growth 140.53%
- Ebitda 770.41%
- Net Worth 20.58%
- Total Assets -0.57%
About Xiocare Life Sciences
Xiocare Life Sciences Private Limited (XLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 November 2011 and has a history of 13 years and three months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹5.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Santosh Kumar and Sima Shukla serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85191UP2011PTC047248
-
Company No.
047248
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Nov 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Xiocare Life Sciences Private Limited offer?
Xiocare Life Sciences Private Limited offers a wide range of products and services, including Paracetamol Tablets, Crocin Advance Tablet, Crocin Tablets.
Who are the key members and board of directors at Xiocare Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Kumar
|
Director | 02-Nov-2011 | Current |
|
Sima Shukla
|
Additional Director | 22-Nov-2023 | Current |
Financial Performance of Xiocare Life Sciences.
Xiocare Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.95% increase. The company also saw a substantial improvement in profitability, with a 140.53% increase in profit. The company's net worth Soared by an impressive increase of 20.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Xiocare Life Sciences?
In 2020, Xiocare Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹5.00 M
Charges Breakdown by Lending Institutions
- Corporation Bank : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2014 | Corporation Bank | ₹5.00 M | Satisfied |
How Many Employees Work at Xiocare Life Sciences?
Xiocare Life Sciences has a workforce of 16 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xiocare Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xiocare Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
